Multibagger Selection: DeepSeek's picks
DeepSeek picked ECX, NTWK, AKAM, SRRK, ELVA with a twelve-month thesis, measured against SPY at each checkpoint.
| Experiment | Multibagger Selection |
|---|---|
| Model | DeepSeek |
| Prompt version | multibagger-selection-v1 |
| Asked | |
| Horizon | 12-month |
| Benchmark | SPY |
| Status | Being measured |
The picks
| Rank | Symbol | Return | Confidence | vs benchmark | Called right |
|---|---|---|---|---|---|
| 1 | ECX | — | 75% | — | — |
| 2 | NTWK | — | 70% | — | — |
| 3 | AKAM | — | 65% | — | — |
| 4 | SRRK | — | 60% | — | — |
| 5 | ELVA | — | 55% | — | — |
Checkpoints
| Checkpoint | Portfolio return | Return vs SPY | Best peak multiple | Picks reaching 2x |
|---|---|---|---|---|
| 1 week | -1.98% | -2.63% | 1.25x | 0 |
The model's market view
The current environment for small and mid-cap multibagger candidates is mixed. While geopolitical tensions and rate uncertainty create headwinds for the broader market, select companies with strong secular growth drivers and specific catalysts can still deliver outsized returns. Focus is on names with visible paths to profitability, improving cash flows, and differentiated technologies.
Why each pick
ECX
ECARX is a global mobility tech company powering software-defined vehicles. The company reported Q2 2026 revenue up 44.7% with gross profit jumping 164.9%. Strong revenue acceleration and margin expansion point to a fundamental inflection. The catalyst is the ongoing commercial ramp with major automakers. Risks include customer concentration and competition. The reference price is the latest close.
NTWK
NETSOL Technologies reported record fiscal 2026 revenue of $74.4 million, exceeding guidance, with full-year profitability. The company provides software to OEMs. The catalyst is the recent earnings beat and guidance exceedance, which could drive analyst upgrades. Risks include small size and liquidity. The reference price is the latest close.
AKAM
Akamai signed an $11.6 billion, seven-year cloud infrastructure deal with Anthropic, the largest in its history. This deal provides significant revenue visibility and validates its cloud computing strategy. Risks include execution and competition from larger cloud providers. The reference price is the latest close.
SRRK
Scholar Rock has a PDUFA date of September 30, 2026, for its SMA therapy apitegromab. FDA approval could be a major catalyst, unlocking significant market potential. Risks include a complete response letter. The reference price is the latest close.
ELVA
Electrovaya announced a new agreement with Amazon, a major catalyst for the lithium-ion battery maker. The deal could drive significant revenue growth. Risks include execution and competition. The reference price is the latest close.
Other models on the same run
| Model | Picks |
|---|---|
| Gemini 1.5 Pro | MGNI, IONQ, RXRX, LUNR, ACHR |
| Perplexity | LWLG, SATL, ARTV, KOD, TYGO |
| Claude Opus 5.5 | CAPR, EOSE, QMCO, KOD, ETON |
| Muse Spark 1.1 | EXTR, TLS, EVLV, SOUN, BBAI |
| Grok 4 | CAPR, INOD, SOUN, ACHR, RCAT |
| GPT-6 | BKSY, AMPX, ENVX, RCAT, LUNR |
ForecastNest provides AI-generated market analysis and quantitative research for informational and educational purposes only. Nothing here constitutes financial, investment, legal, or tax advice.